US Broker Ratings

Centessa Pharmaceuticals (CNTA) Stock Analysis: Unpacking a 52.47% Upside Potential in Biotech

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is capturing investor attention with its robust growth potential in the biotechnology sector. As a clinical-stage pharmaceutical company, Centessa is focused on discovering, developing, and..

Celldex Therapeutics (CLDX) Investor Outlook: Analysts See Over 100% Upside Potential

For investors seeking promising opportunities in the biotechnology sector, Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents a compelling case. This New Jersey-based biopharmaceutical company is dedicated to developing therapeutic antibodies targeted..

Sotera Health Company (SHC) Stock Analysis: A 9.94% Potential Upside with Robust Revenue Growth

Sotera Health Company (SHC), a key player in the healthcare sector specializing in diagnostics and research, stands out for its strategic positioning and growth potential. With a market capitalization of..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: A 198% Potential Upside for Investors

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a biotechnology firm specializing in the development of oral small-molecule and injectable protein therapeutics for rare diseases, is capturing investor attention with a compelling upside..

Immunocore Holdings plc (IMCR) Stock Analysis: Unveiling an 89% Potential Upside in Biotechnology

Immunocore Holdings plc (IMCR), a leading name in the biotechnology sector, is capturing investor attention with its robust pipeline of immunotherapies and a striking potential upside of 89.27%. Headquartered in..

MannKind Corporation (MNKD) Stock Analysis: Why a 72% Upside Could Attract Investors

MannKind Corporation (NASDAQ: MNKD), a biopharmaceutical company specializing in therapeutic products for endocrine and orphan lung diseases, has recently captured the attention of investors with its impressive potential upside of..

Acadia Healthcare (ACHC) Stock Analysis: Is a 25% Upside Worth the Risk?

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a key player in the healthcare sector, specifically within the medical care facilities industry. Known for its comprehensive range of behavioral healthcare services,..

Select Medical Holdings Corp (SEM) Stock Analysis: A 21% Upside Potential in Healthcare

Select Medical Holdings Corp (NYSE: SEM) is garnering attention from investors as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..

Ligand Pharmaceuticals (LGND) Stock Analysis: Unveiling a 22.82% Upside Potential

For investors seeking opportunities in the dynamic biotechnology sector, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presents a compelling case. With a robust pipeline of biopharmaceutical assets, Ligand is a key player..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 29.79% Upside Potential in the Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is making waves in the medical devices industry with its innovative solutions and robust market presence. Based in Newburyport, Massachusetts, the company is a key..

BGM Group Ltd. (BGM) Stock Analysis: Navigating the Complexities of a Volatile Market with Innovative Healthcare Products

BGM Group Ltd. (BGM) operates in the highly competitive healthcare sector, focusing on the drug manufacturing industry, specializing in both specialty and generic medications. Based in Chengdu, China, BGM has..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Navigating Biotech Innovation with a 22.59% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is a compelling player in the biotechnology sector, commanding attention with a robust market capitalization of $9.32 billion. Specializing in the development of innovative medicines..

CONMED Corporation (CNMD): Stock Analysis Reveals 18% Potential Upside Amidst Healthcare Sector Dynamics

CONMED Corporation (NASDAQ: CNMD), a key player in the healthcare sector, has been making waves with its specialized focus on medical devices designed for surgical procedures. Headquartered in Largo, Florida,..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Strong Buy with 43.5% Revenue Growth

Alignment Healthcare, Inc. (ALHC), a prominent player in the healthcare plans industry, has garnered significant attention from investors, thanks to its impressive revenue growth and a suite of favorable analyst..

Liquidia Corporation (LQDA) Investor Outlook: A Biotech Stock Riding High on 1,121.70% Revenue Growth

Liquidia Corporation (NASDAQ: LQDA) has captured the spotlight with its remarkable revenue growth of 1,121.70%, positioning itself as a notable player in the biotechnology sector. Based in Morrisville, North Carolina,..

Envista Holdings Corporation (NVST) Investor Outlook: Navigating a 11.50% Revenue Growth in the Healthcare Sector

Envista Holdings Corporation (NYSE: NVST) stands out in the healthcare sector as a significant player in the medical instruments and supplies industry. With a market capitalization of $4 billion, this..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Potential 44.88% Upside Fuels Investor Interest

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands out in the biotechnology landscape with a compelling precision medicine approach to oncology. With a market capitalization of $3.02 billion, this healthcare sector innovator..

Travere Therapeutics (TVTX) Stock Analysis: Exploring a 40% Upside in Rare Disease Biotechnology

Travere Therapeutics, Inc. (TVTX) is making waves in the biotechnology sector, particularly in the niche of rare kidney and metabolic diseases. With a market cap of $2.68 billion and a..

ImmunityBio, Inc. (IBRX) Stock Analysis: Potential Upside of 90% for This Biotech Innovator

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing the attention of investors with its impressive potential upside of 90%, according to average analyst target prices. As a biotechnology firm focused on harnessing..

Addus HomeCare Corporation (ADUS) Investor Outlook: Assessing the 27.75% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS), a stalwart in the healthcare sector, has caught the attention of investors with its promising potential upside of 27.75%. This figure is not just a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds